Insider Transactions in Q2 2025 at Procter & Gamble CO (PG)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2025
|
Ashley Mc Evoy Director |
BUY
Grant, award, or other acquisition
|
Direct |
185
+4.84%
|
-
|
|
Jun 10
2025
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
292
+0.86%
|
-
|
|
Jun 10
2025
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
223
+0.52%
|
-
|
|
Jun 10
2025
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
231
+1.56%
|
-
|
|
Jun 10
2025
|
Robert Jones Portman Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+1.38%
|
-
|
|
Jun 10
2025
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
185
+0.36%
|
-
|
|
Jun 10
2025
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
45
+8.09%
|
-
|
|
Jun 10
2025
|
Christopher J Kempczinski Director |
BUY
Grant, award, or other acquisition
|
Direct |
185
+2.03%
|
-
|
|
Jun 09
2025
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
466
+50.0%
|
-
|
|
May 05
2025
|
Moses Victor Javier Aguilar Chf Rsch, Dev & Innov Officer |
SELL
Open market or private sale
|
Direct |
10,520
-29.47%
|
$1,662,160
$158.67 P/Share
|
|
May 05
2025
|
Moses Victor Javier Aguilar Chf Rsch, Dev & Innov Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,520
+22.76%
|
$841,600
$80.29 P/Share
|
|
Apr 29
2025
|
Jennifer L. Davis CEO - Health Care |
SELL
Open market or private sale
|
Direct |
1,000
-1.89%
|
$161,000
$161.38 P/Share
|